Literature DB >> 19686080

How the fanconi anemia pathway guards the genome.

George-Lucian Moldovan1, Alan D D'Andrea.   

Abstract

Fanconi Anemia (FA) is an inherited genomic instability disorder, caused by mutations in genes regulating replication-dependent removal of interstrand DNA crosslinks. The Fanconi Anemia pathway is thought to coordinate a complex mechanism that enlists elements of three classic DNA repair pathways, namely homologous recombination, nucleotide excision repair, and mutagenic translesion synthesis, in response to genotoxic insults. To this end, the Fanconi Anemia pathway employs a unique nuclear protein complex that ubiquitinates FANCD2 and FANCI, leading to formation of DNA repair structures. Lack of obvious enzymatic activities among most FA members has made it challenging to unravel its precise modus operandi. Here we review the current understanding of how the Fanconi Anemia pathway components participate in DNA repair and discuss the mechanisms that regulate this pathway to ensure timely, efficient, and correct restoration of chromosomal integrity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19686080      PMCID: PMC2830711          DOI: 10.1146/annurev-genet-102108-134222

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  171 in total

1.  Cancer in Fanconi anemia.

Authors:  Blanche P Alter; Mark H Greene; Isela Velazquez; Philip S Rosenberg
Journal:  Blood       Date:  2003-03-01       Impact factor: 22.113

2.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.

Authors:  Susan M Gordon; Manuel Buchwald
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

4.  A novel ubiquitin ligase is deficient in Fanconi anemia.

Authors:  Amom Ruhikanta Meetei; Johan P de Winter; Annette L Medhurst; Michael Wallisch; Quinten Waisfisz; Henri J van de Vrugt; Anneke B Oostra; Zhijiang Yan; Chen Ling; Colin E Bishop; Maureen E Hoatlin; Hans Joenje; Weidong Wang
Journal:  Nat Genet       Date:  2003-09-14       Impact factor: 38.330

5.  Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links.

Authors:  Deepa Sridharan; Monique Brown; W Clark Lambert; Laura W McMahon; Muriel W Lambert
Journal:  J Cell Sci       Date:  2003-03-01       Impact factor: 5.285

6.  Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia.

Authors:  Jasmine C Y Wong; Noa Alon; Colin Mckerlie; Jun R Huang; M Stephen Meyn; Manuel Buchwald
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

7.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

8.  Characterization of the DNA damage-inducible helicase DinG from Escherichia coli.

Authors:  Oleg N Voloshin; Filip Vanevski; Pavel P Khil; R Daniel Camerini-Otero
Journal:  J Biol Chem       Date:  2003-05-14       Impact factor: 5.157

9.  Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.

Authors:  Toshiyasu Taniguchi; Marc Tischkowitz; Najim Ameziane; Shirley V Hodgson; Christopher G Mathew; Hans Joenje; Samuel C Mok; Alan D D'Andrea
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

Review 10.  The Fanconi anaemia/BRCA pathway.

Authors:  Alan D D'Andrea; Markus Grompe
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

View more
  296 in total

1.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.

Authors:  Patrizia Vinciguerra; Susana A Godinho; Kalindi Parmar; David Pellman; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

3.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Authors:  Maria Castella; Roser Pujol; Elsa Callén; Juan P Trujillo; José A Casado; Hans Gille; Francis P Lach; Arleen D Auerbach; Detlev Schindler; Javier Benítez; Beatriz Porto; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Luis Madero; Elena Cela; Cristina Beléndez; Cristina Díaz de Heredia; Teresa Olivé; José Sánchez de Toledo; Isabel Badell; Montserrat Torrent; Jesús Estella; Angeles Dasí; Antonia Rodríguez-Villa; Pedro Gómez; José Barbot; María Tapia; Antonio Molinés; Angela Figuera; Juan A Bueren; Jordi Surrallés
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 4.  Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes.

Authors:  Marina Pajic; Christopher J Scarlett; David K Chang; Robert L Sutherland; Andrew V Biankin
Journal:  Hum Genet       Date:  2011-04-23       Impact factor: 4.132

Review 5.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

6.  Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.

Authors:  Enrico Cappelli; Donatella Vecchio; Guido Frosina
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-07       Impact factor: 4.553

Review 7.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

8.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

9.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

Authors:  Raphael Ceccaldi; Kalindi Parmar; Enguerran Mouly; Marc Delord; Jung Min Kim; Marie Regairaz; Marika Pla; Nadia Vasquez; Qing-Shuo Zhang; Corinne Pondarre; Régis Peffault de Latour; Eliane Gluckman; Marina Cavazzana-Calvo; Thierry Leblanc; Jérôme Larghero; Markus Grompe; Gérard Socié; Alan D D'Andrea; Jean Soulier
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

Review 10.  Spectrin and its interacting partners in nuclear structure and function.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.